Truist Securities Reiterates Hold on Insulet, Raises Price Target to $160
Benzinga Newsdesk 5 hours ago
Analyst RatingsNewsReiterationPrice Target
Truist Securities analyst Richard Newitter reiterates Insulet (NASDAQ:PODD) with a Hold and raises the price target from $153 to $160.
Truist Securities analyst Richard Newitter reiterates Insulet (NASDAQ:PODD) with a Hold and raises the price target from $153 to $160.
